543 related articles for article (PubMed ID: 37496815)
1. A retrospective analysis of clinical outcomes between hospitalized patients with COVID-19 who received famotidine or pantoprazole.
Wagner JJ; St Cyr N; Douen A; Fogel J; Trillo J
JGH Open; 2023 Jul; 7(7):464-469. PubMed ID: 37496815
[TBL] [Abstract][Full Text] [Related]
2. Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation.
Ojiako K; Shingala H; Schorr C; Gerber DR
Am J Crit Care; 2008 Mar; 17(2):142-7. PubMed ID: 18310651
[TBL] [Abstract][Full Text] [Related]
3. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
Ng FH; Wong SY; Lam KF; Chu WM; Chan P; Ling YH; Kng C; Yuen WC; Lau YK; Kwan A; Wong BC
Gastroenterology; 2010 Jan; 138(1):82-8. PubMed ID: 19837071
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection.
Jeong HK; Park CH; Jun CH; Lee GH; Kim HI; Kim HS; Choi SK; Rew JS
J Korean Med Sci; 2007 Dec; 22(6):1055-9. PubMed ID: 18162722
[TBL] [Abstract][Full Text] [Related]
5. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs.
Kuhl A; Odunayo A; Price J; Hecht S; Marshall K; Steiner J; Tolbert MK
J Vet Intern Med; 2020 Mar; 34(2):678-683. PubMed ID: 32020689
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
Aliment Pharmacol Ther; 2001 Jul; 15(7):917-26. PubMed ID: 11421865
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies.
Lin KJ; Feldman WB; Wang SV; Pramod Umarje S; D'Andrea E; Tesfaye H; Zabotka LE; Liu J; Desai RJ
J Clin Epidemiol; 2022 Nov; 151():45-52. PubMed ID: 35868493
[TBL] [Abstract][Full Text] [Related]
9. Hypertension and Gastrointestinal Bleed in COVID-19 Patients: Associations with Mortality, Acute Kidney Injury, Vasopressor Use, and Mechanical Ventilation Use.
Brodskiy I; Fogel J; Douen A; Wagner J; Trillo J
Folia Med Cracov; 2023 Dec; 63(4):99-108. PubMed ID: 38578349
[TBL] [Abstract][Full Text] [Related]
10. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
Bersenas AM; Mathews KA; Allen DG; Conlon PD
Am J Vet Res; 2005 Mar; 66(3):425-31. PubMed ID: 15822586
[TBL] [Abstract][Full Text] [Related]
11. Effect of famotidine on hospitalized patients with COVID-19: A systematic review and meta-analysis.
Chiu L; Shen M; Lo CH; Chiu N; Chen A; Shin HJ; Prsic EH; Hur C; Chow R; Lebwohl B
PLoS One; 2021; 16(11):e0259514. PubMed ID: 34735523
[TBL] [Abstract][Full Text] [Related]
12. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intravenous administration of combined acid suppressants in healthy dogs.
Tolbert MK; Odunayo A; Howell RS; Peters EE; Reed A
J Vet Intern Med; 2015; 29(2):556-60. PubMed ID: 25711717
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.
Samimagham HR; Hassani Azad M; Haddad M; Arabi M; Hooshyar D; KazemiJahromi M
Trials; 2020 Oct; 21(1):848. PubMed ID: 33050945
[TBL] [Abstract][Full Text] [Related]
15. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.
Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D;
Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708
[TBL] [Abstract][Full Text] [Related]
16. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
[TBL] [Abstract][Full Text] [Related]
17. Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients.
Hogan Ii RB; Hogan Iii RB; Cannon T; Rappai M; Studdard J; Paul D; Dooley TP
Pulm Pharmacol Ther; 2020 Aug; 63():101942. PubMed ID: 32871242
[TBL] [Abstract][Full Text] [Related]
18. Effects of pantoprazole on ulcer healing delay associated with NSAID treatment.
Fornai M; Colucci R; Antonioli L; Ghisu N; Tuccori M; Blandizzi C; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):305-13. PubMed ID: 18853145
[TBL] [Abstract][Full Text] [Related]
19. Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort study.
Chen WC; Li YD; Chiang PH; Tsay FW; Chan HH; Tsai WL; Tsai TJ; Wang EM; Cheng JS; Lai KH
Biomed Res Int; 2014; 2014():693567. PubMed ID: 25295267
[TBL] [Abstract][Full Text] [Related]
20. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
